{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:42Z","timestamp":1766514162234,"version":"3.44.0"},"reference-count":33,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1136\/dtb.2020.232117rep","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T17:15:12Z","timestamp":1592673312000},"page":"157-159","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Republished: Rifampicin induced shock during re-exposure for treatment of latent tuberculosis"],"prefix":"10.1136","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-0594","authenticated-orcid":false,"given":"Christopher Francis","family":"Harlow","sequence":"first","affiliation":[{"name":"Department of Chest and Allergy, St Mary\u2019s Hospital, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamilah","family":"Meghji","sequence":"additional","affiliation":[{"name":"Department of Chest and Allergy, St Mary\u2019s Hospital, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Chest and Allergy, St Mary\u2019s Hospital, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Chest and Allergy, St Mary\u2019s Hospital, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onn Min","family":"Kon","sequence":"additional","affiliation":[{"name":"Department of Chest and Allergy, St Mary\u2019s Hospital, Imperial College Healthcare NHS Trust, London, UK"},{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"key":"2025082623255430000_58.10.157.1","unstructured":"NICE guidelines . Managing latent tuberculosis. Available: https:\/\/pathways.nice.org.uk\/pathways\/tuberculosis#path=view%3A\/pathways\/tuberculosis\/managing-latent-tuberculosis.xml&content=view-index [Accessed 18 Apr 2019]."},{"key":"2025082623255430000_58.10.157.2","unstructured":"Rifampicin . British National formulary. London: BMJ Group and Pharmaceutical Press, 2019. https:\/\/bnf.nice.org.uk\/drug\/rifampicin.html"},{"key":"2025082623255430000_58.10.157.3","unstructured":"Rifampin, Toxnet. Available: https:\/\/toxnet.nlm.nih.gov\/cgi-bin\/sis\/search2\/r?dbs+hsdb:@term+@rn+@rel+13292-46-1"},{"key":"2025082623255430000_58.10.157.4","first-page":"97","article-title":"Results of a surveillance system for adverse effects in leprosy's WHO\/MDT","volume":"64","author":"Brasil","year":"1996","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"2025082623255430000_58.10.157.5","unstructured":"Hardman JG , Limbird LE , Gilman AG . Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th edn. New York: McGraw-Hill, 2001: 1279."},{"key":"2025082623255430000_58.10.157.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5803.765"},{"key":"2025082623255430000_58.10.157.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/3.5.445"},{"key":"2025082623255430000_58.10.157.8","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199911000-00001"},{"key":"2025082623255430000_58.10.157.9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40360-019-0289-7","article-title":"Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including who spontaneous safety reports","volume":"20","author":"Brockhaus","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"2025082623255430000_58.10.157.10","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2014.4.1.54"},{"key":"2025082623255430000_58.10.157.11","first-page":"1935","article-title":"[Case of severe shock following repeated administration of rifampicin]","volume":"33","author":"Cesarz-Fronczyk","year":"1978","journal-title":"Pol Tyg Lek"},{"key":"2025082623255430000_58.10.157.12","first-page":"509","article-title":"[Anaphylactic shock after readministration of rifampicin: a case report]","volume":"50","author":"Chiang","year":"1992","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2025082623255430000_58.10.157.13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.rmr.2010.06.009","article-title":"Manifestations d\u2019hypersensibilit\u00e9 aux antituberculeux","volume":"27","author":"Fekih","year":"2010","journal-title":"Rev Mal Respir"},{"key":"2025082623255430000_58.10.157.14","first-page":"25","article-title":"A case of allergic shock caused by readministration of rifampicin]","volume":"62","author":"Hashimoto","year":"1987","journal-title":"Kekkaku"},{"key":"2025082623255430000_58.10.157.15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijtb.2016.06.002","article-title":"Anaphylaxis to rifampicin and pyrazinamide in a child with tuberculous meningitis: a case report","volume":"64","author":"Nadri","year":"2017","journal-title":"Indian J Tuberc"},{"key":"2025082623255430000_58.10.157.16","first-page":"277","article-title":"Serious side effects of rifampin on the course of WHO\/MDT: a case report","volume":"68","author":"Namisato","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"2025082623255430000_58.10.157.17","first-page":"596","article-title":"Hypersensitivity reaction to all drugs of category-1 anti-tuberculosis regime in an adult tuberculosis patient","volume":"22","author":"Rashid","year":"2013","journal-title":"Mymensingh Med J"},{"key":"2025082623255430000_58.10.157.18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/SMJ.0b013e3180f60a57","article-title":"Life-Threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis","volume":"100","author":"Luzzati","year":"2007","journal-title":"South Med J"},{"key":"2025082623255430000_58.10.157.19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4168\/aair.2014.6.2.183","article-title":"A case of serum sickness-like reaction and anaphylaxis - induced simultaneously by rifampin","volume":"6","author":"Kim","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"2025082623255430000_58.10.157.20","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e318292cbd0"},{"key":"2025082623255430000_58.10.157.21","first-page":"771","article-title":"[Mechanism of hypotension induced by rifampicin during intravenous administration]","volume":"33","author":"Berezhinskaia","year":"1988","journal-title":"Antibiot Khimioter"},{"key":"2025082623255430000_58.10.157.22","unstructured":"NICE clinical guideline . Nice: anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode, 2019. https:\/\/www.nice.org.uk\/guidance\/cg134\/documents\/anaphylaxis-full-guideline2"},{"key":"2025082623255430000_58.10.157.23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/1742-6723.12875","article-title":"Serum mast cell tryptase measurements: sensitivity and specificity for a diagnosis of anaphylaxis in emergency department patients with shock or hypoxaemia","volume":"30","author":"Francis","year":"2018","journal-title":"Emerg Med Australas"},{"key":"2025082623255430000_58.10.157.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80222-2"},{"key":"2025082623255430000_58.10.157.25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000091839","article-title":"Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance","volume":"140","author":"Buergin","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"2025082623255430000_58.10.157.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00547.x"},{"key":"2025082623255430000_58.10.157.27","unstructured":"Philadelphia Tuberculosis Control Program . Guidelines for the management of adverse drug effects of antimycobacterial agent. Philadelphia, 1998."},{"key":"2025082623255430000_58.10.157.28","article-title":"Acute renal failure and anaphylactic shock induced by rifampicin","volume":"185","author":"Ko","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025082623255430000_58.10.157.29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2018.01.006","article-title":"Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs","volume":"68","author":"Siripassorn","year":"2018","journal-title":"Int J Infect Dis"},{"key":"2025082623255430000_58.10.157.30","article-title":"Desensibilizaci\u00f3n a rifampicina. A prop\u00f3sito de un caso","volume":"106","author":"Alonso","year":"1996","journal-title":"Medicina Clinica"},{"key":"2025082623255430000_58.10.157.31","article-title":"Antituberculous drug desensitization","volume":"103","author":"Abong","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"2025082623255430000_58.10.157.32","first-page":"431","article-title":"Oral desensitization with antituberculosis drugs","volume":"99","author":"Alvarez Cuesta","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"2025082623255430000_58.10.157.33","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt446"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2020.232117rep","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:26:07Z","timestamp":1756275967000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2020.232117rep"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,28]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/dtb.2020.232117rep"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2020.232117rep","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2020,6,20]]}}}